SCHEMBL21796353

SCHEMBL21796353

CC(Nc1nccnc1-c1ccc(NC(=O)Cc2ccc(C(F)(F)C(C)O)cc2)cc1)c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ MEN1 O00255 5/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ MAPT P10636 3/20 0.40
▸ CNR2 P34972 1/20 0.40
▸ LMNA P02545 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ NR2E1 Q9Y466 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ HPGD P15428 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ RORC P51449 3/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ PSEN1 P49768 1/20 0.38
▸ PSEN2 P49810 1/20 0.38
▸ APH1B Q8WW43 1/20 0.38
▸ NCSTN Q92542 1/20 0.38
▸ APH1A Q96BI3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19205657 1.00 NPC1 (0.42) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL18448917 0.90 NPC1 (0.49) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL19205758 0.90 MEN1 (0.42) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL19205756 0.90 MEN1 (0.42) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL19205763 0.86 TRPV1 (0.40) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL21796351 0.86 TRPV1 (0.40) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL21796354 0.82 SMN1; SMN2 (0.40) RAB9AMEN1KMT2ASMN1; SMN2RORC
SCHEMBL18449664 0.82 SMN1; SMN2 (0.40) RAB9AMEN1KMT2ASMN1; SMN2RORC
SCHEMBL18447581 0.81 GAA (0.52) MEN1KMT2ASMN1; SMN2ALDH1A1HPGD
SCHEMBL18448346 0.81 RORC (0.50) MEN1KMT2AMAPTNR2E1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3331863-B1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS SA (CH) 2020-03-11 — — EP claimed
EP-3686187-A1 PROCESS FOR THE PREPARATION OF ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2020-07-29 — — EP disclosed
Send feedback